Correction: 18F-FDG PET can effectively rule out conversion to dementia and the presence of CSF biomarker of neurodegeneration: a real-world data analysis

Correction: ¹⁸F-FDG PET can effectively rule out conversion to dementia and the presence of CSF biomarker of neurodegeneration: a real-world data analysis

Alzheimers Res Ther. 2024 Nov 13;16(1):247. doi: 10.1186/s13195-024-01608-3.

Sébastien Heyer¹, Maïa Simon², Matthieu Doyen^{1

3}, Ali Mortada¹, Véronique Roch¹, Elodie Jeanbert², Nathalie Thilly², Catherine Malaplate⁴, Anna Kearney-Schwartz^{5

6}, Thérèse Jonveaux^{6

7}, Aurélie Bannay⁸, Antoine Verger^{9

10}

¹ Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy, Nancy, F-54000, France.
² Department of Methodology, Promotion and Investigation, Université de Lorraine, CHRU-Nancy, Nancy, F-54000, France.
³ Université de Lorraine, IADI, INSERM U1254, Nancy, F-54000, France.
⁴ Department of Biochemistry, Université de Lorraine, CHRU-Nancy, Nancy, F-54000, France.
⁵ Department of Geriatrics, Université de Lorraine, CHRU-Nancy, Nancy, F-54000, France.
⁶ CMRR, University Hospital Nancy, Nancy, F-54000, France.
⁷ Department of Neurology, University Hospital Nancy, Nancy, F-54000, France.
⁸ Medical Assessment and Information Department, Université de Lorraine, CHRU-Nancy, Nancy, 54000, France.
⁹ Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy, Nancy, F-54000, France. [email protected].
¹⁰ Université de Lorraine, IADI, INSERM U1254, Nancy, F-54000, France. [email protected].

No abstract available